Skip to main content

Research Repository

Advanced Search

Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease

Mells, George; ARAVINTHAN, ALOYSIOUS; Allison, Michael; Leathart, Julian; Kotronen, Anna; Yki-Jarvinen, Hannele; Daly, Ann K; Day, Christopher P; Anstee, Quentin M; Alexander, Graeme

Authors

George Mells

Michael Allison

Julian Leathart

Anna Kotronen

Hannele Yki-Jarvinen

Ann K Daly

Christopher P Day

Quentin M Anstee

Graeme Alexander



Abstract

Non-alcohol-related fatty liver disease (NAFLD) encompasses a wide spectrum, ranging from steatosis alone to steatohepatitis and fibrosis. Presence of steatohepatitis and fibrosis are key hallmarks of disease progression. Previous studies have demonstrated an association between hepatocyte p21 expression and fibrosis stage in NAFLD. The aim of this study is to investigate the association between the variants of CDKN1A, which encodes p21, and disease progression in NAFLD. To this end, the relation between CDKN1A polymorphism and liver fibrosis was studied in 2 cohorts of biopsy-proven NAFLD patients from UK (n = 323) and Finland (n = 123). Genotyping was performed using DNA isolated from lymphocytes collected at the time of liver biopsy. The findings of the UK cohort were tested in the Finnish cohort. Both the UK and Finnish cohorts were significantly different from each other in basic demographics. In the UK cohort, rs762623, of the 6 SNPs across CDKN1A tested, was significantly associated with disease progression in NAFLD. This association was confirmed in the Finnish cohort. Despite the influence on fibrosis development, SNPs across CDKN1A did not affect the progression of liver fibrosis. In conclusion, CDKN1A variant rs762623 is associated with the development but not the propagation of progressive liver disease in NAFLD.

Citation

Mells, G., ARAVINTHAN, A., Allison, M., Leathart, J., Kotronen, A., Yki-Jarvinen, H., Daly, A. K., Day, C. P., Anstee, Q. M., & Alexander, G. (2014). Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease. Cell Cycle, 13(9), 1489-1494. https://doi.org/10.4161/cc.28471

Journal Article Type Article
Acceptance Date Jul 3, 2014
Online Publication Date Mar 11, 2014
Publication Date Mar 15, 2014
Deposit Date Jul 22, 2018
Print ISSN 1538-4101
Electronic ISSN 1551-4005
Publisher Taylor & Francis Open
Peer Reviewed Peer Reviewed
Volume 13
Issue 9
Pages 1489-1494
DOI https://doi.org/10.4161/cc.28471
Public URL https://nottingham-repository.worktribe.com/output/1119942
Publisher URL https://www.tandfonline.com/doi/full/10.4161/cc.28471
PMID 24626178